ERBB2 and breast carcinoma: Upon further characterization of BT474 PTEN− LTT cells, we identified that expression of classical breast cancer cell markers ER, PR, and HER2 were all significantly reduced at mRNA and protein level both in vitro and in vivo, while expression of proliferation marker Ki-67 was increased.